Medasense

MedasenseMedasense
Medasense

Medasense

Medasense quantifies pain response using breakthrough NOL® AI technology to optimize patient care and avoid overmedication.

Website
2008Active26
Rate
Advertise here

About

Medasense is transforming pain assessment and treatment globally. Their breakthrough NOL® AI technology and sensing platform objectively quantify pain response, enabling clinicians to optimize care and prevent overmedication. The flagship product, PMD-200™, is utilized in critical care settings.

Technology stack

detected 2026-07-01
EmailMicrosoft 365
Hosting
Google Cloud
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Medasense do?

Medasense is transforming pain assessment and treatment globally. Their breakthrough NOL® AI technology and sensing platform objectively quantify pain response, enabling clinicians to optimize care and prevent overmedication. The flagship product, PMD-200™, is utilized in critical care settings.

How much funding has Medasense raised?

Medasense has raised a total of $40M in funding. The most recent round on record is Series C.

Where is Medasense headquartered?

Medasense is headquartered in Tel Aviv, Israel.

When was Medasense founded?

Medasense was founded in 2008.

What industry does Medasense operate in?

Medasense operates in Pain, Patient Care, Monitoring, Surgery, Healthcare, Digital Health.

How many employees does Medasense have?

Medasense has approximately 26 people on record.

What is Medasense's valuation?

StartupHub estimates Medasense's effective valuation at $161.6M (range $99.0M to $237.6M, 10% confidence), based on comparable companies in the sector.